A detailed history of Hayek Kallen Investment Management transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Hayek Kallen Investment Management holds 10,775 shares of TMO stock, worth $5.65 Million. This represents 2.36% of its overall portfolio holdings.

Number of Shares
10,775
Previous 10,970 1.78%
Holding current value
$5.65 Million
Previous $6.07 Million 9.87%
% of portfolio
2.36%
Previous 2.26%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$531.86 - $624.21 $103,712 - $121,720
-195 Reduced 1.78%
10,775 $6.67 Million
Q2 2024

Jul 18, 2024

SELL
$541.52 - $599.02 $12,996 - $14,376
-24 Reduced 0.22%
10,970 $6.07 Million
Q1 2024

May 03, 2024

SELL
$528.82 - $599.43 $44,949 - $50,951
-85 Reduced 0.77%
10,994 $6.39 Million
Q4 2023

Feb 08, 2024

SELL
$431.41 - $532.94 $23,727 - $29,311
-55 Reduced 0.49%
11,079 $5.88 Million
Q3 2023

Nov 07, 2023

SELL
$498.29 - $574.41 $86,702 - $99,947
-174 Reduced 1.54%
11,134 $5.64 Million
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $25,423 - $29,556
50 Added 0.44%
11,308 $5.9 Million
Q1 2023

May 08, 2023

SELL
$535.0 - $604.82 $572,450 - $647,157
-1,070 Reduced 8.68%
11,258 $6.49 Million
Q4 2022

Feb 09, 2023

SELL
$484.71 - $571.37 $260,289 - $306,825
-537 Reduced 4.17%
12,328 $6.79 Million
Q3 2022

Oct 19, 2022

SELL
$507.19 - $604.49 $29,924 - $35,664
-59 Reduced 0.46%
12,865 $6.53 Million
Q2 2022

Aug 11, 2022

SELL
$500.9 - $612.21 $125,225 - $153,052
-250 Reduced 1.9%
12,924 $7.02 Million
Q1 2022

May 09, 2022

SELL
$524.0 - $644.92 $198,596 - $244,424
-379 Reduced 2.8%
13,174 $7.78 Million
Q4 2021

Feb 08, 2022

SELL
$569.0 - $667.24 $250,360 - $293,585
-440 Reduced 3.14%
13,553 $9.04 Million
Q3 2021

Oct 06, 2021

SELL
$509.53 - $609.78 $531,439 - $636,000
-1,043 Reduced 6.94%
13,993 $8 Million
Q2 2021

Aug 12, 2021

SELL
$441.0 - $508.24 $224,469 - $258,694
-509 Reduced 3.27%
15,036 $7.59 Million
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $78,733 - $92,870
-179 Reduced 1.14%
15,545 $7.1 Million
Q4 2020

Feb 12, 2021

SELL
$435.06 - $527.66 $93,537 - $113,446
-215 Reduced 1.35%
15,724 $7.32 Million
Q3 2020

Nov 12, 2020

SELL
$359.77 - $441.52 $219,099 - $268,885
-609 Reduced 3.68%
15,939 $7.04 Million
Q2 2020

Sep 10, 2020

BUY
$275.2 - $362.34 $1,651 - $2,174
6 Added 0.04%
16,548 $6 Million
Q1 2020

Apr 22, 2020

SELL
$255.3 - $340.05 $154,967 - $206,410
-607 Reduced 3.54%
16,542 $4.69 Million
Q4 2019

Feb 13, 2020

SELL
$271.93 - $328.04 $322,237 - $388,727
-1,185 Reduced 6.46%
17,149 $5.57 Million
Q3 2019

Nov 05, 2019

SELL
$268.46 - $305.43 $199,734 - $227,239
-744 Reduced 3.9%
18,334 $5.34 Million
Q2 2019

Jul 17, 2019

SELL
$257.51 - $295.55 $105,321 - $120,879
-409 Reduced 2.1%
19,078 $5.6 Million
Q1 2019

May 09, 2019

SELL
$212.17 - $273.72 $444,283 - $573,169
-2,094 Reduced 9.7%
19,487 $5.33 Million
Q4 2018

Jan 16, 2019

SELL
$208.47 - $251.98 $263,506 - $318,502
-1,264 Reduced 5.53%
21,581 $4.83 Million
Q3 2018

Nov 09, 2018

SELL
$205.57 - $244.32 $134,442 - $159,785
-654 Reduced 2.78%
22,845 $5.58 Million
Q3 2018

Nov 09, 2018

BUY
$205.57 - $244.32 $57,559 - $68,409
280 Added 1.21%
23,499 $4.85 Million
Q2 2018

Aug 03, 2018

SELL
$203.14 - $219.53 $56,879 - $61,468
-280 Reduced 1.19%
23,219 $4.81 Million
Q1 2018

May 10, 2018

SELL
$192.98 - $224.11 $198,576 - $230,609
-1,029 Reduced 4.2%
23,499 $4.85 Million
Q4 2017

Feb 08, 2018

SELL
$182.03 - $200.37 $72,629 - $79,947
-399 Reduced 1.6%
24,528 $4.66 Million
Q3 2017

Oct 25, 2017

BUY
$171.74 - $194.04 $4.28 Million - $4.84 Million
24,927
24,927 $4.72 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Hayek Kallen Investment Management Portfolio

Follow Hayek Kallen Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hayek Kallen Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hayek Kallen Investment Management with notifications on news.